Phase II Study of Avastin, Irinotecan, High Dose 24 Hour Continuous Intravenous Infusion of Floxuridine and Leucovorin in Patients With Previously Untreated Metastatic Colorectal Cancer.

Trial Profile

Phase II Study of Avastin, Irinotecan, High Dose 24 Hour Continuous Intravenous Infusion of Floxuridine and Leucovorin in Patients With Previously Untreated Metastatic Colorectal Cancer.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 15 May 2017

At a glance

  • Drugs Bevacizumab (Primary) ; Floxuridine; Folinic acid; Irinotecan
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Mar 2010 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
    • 16 Mar 2010 Planned end date changed from 1 Mar 2013 to 1 Mar 2010 as reported by ClinicalTrials.gov.
    • 16 Jun 2009 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top